![]() | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (6) | : | MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Index (6) | : | MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Board | : | 6 Index MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
Corporate Action | : | - | ||
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ![]() |
|||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 0 | |
Rating ROA | 1 | |
Rating EQUITY | 5 | |
Rating ROE | 0 | |
Rating DER | 4 | |
Rating TOTAL | 1 |
MARKET CAPITALIZATION | ||
Listed Share | 5.562.386.000 | |
Price | Rp. 725 | |
Capitalization | Rp. 4.032.729.850.000 | |
OWNERSHIP | ||
Listing Date : 04-Jul-01 | ||
Lokal 10,00 % | Asing 0,11 % | Lainnya 89,89 % |
![]() | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (6) | : | MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Index (6) | : | MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Board | : | 6 Index MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
Corporate Action | : | - | ||
Description | 3Q17 | 3Q18 | 3Q19 | 3Q20 | 3Q21 | 3Q22 | 3Q23 | CAGR 5Y(%) |
Last Price | 2740 | 2550 | 2900 | 2890 | 2400 | 1250 | 700 | |
Market Cap | 15.2 T | 14.2 T | 16.1 T | 16.1 T | 13.3 T | 6.9 T | 3.9 T | -72.54 |
BALANCE SHEET | ||||||||
Cash | 626.0 B | 1.4 T | 574.3 B | 749.8 B | 661.1 B | 734.3 B | 792.7 B | -43.38 |
Total Asset | 5.7 T | 8.6 T | 17.9 T | 17.7 T | 18.8 T | 18.7 T | 20.6 T | 139.53 |
S.T.Borrowing | 2.1 T | 3.8 T | 6.3 T | 7.3 T | 7.3 T | 7.0 T | 8.8 T | |
L.T.Borrowing | 1.2 T | 2.1 T | 3.6 T | 3.5 T | 4.3 T | 4.3 T | 2.3 T | |
Total Equity | 2.4 T | 2.8 T | 7.9 T | 6.9 T | 7.2 T | 7.3 T | 9.4 T | 235.71 |
INCOME STATEMENT | ||||||||
Revenue | 4.3 T | 6.0 T | 6.9 T | 7.0 T | 9.5 T | 7.1 T | 7.7 T | 28.33 |
Gross Profit | 1.5 T | 2.4 T | 2.5 T | 2.6 T | 3.3 T | 2.5 T | 2.8 T | 16.67 |
Operating Profit | 1.5 T | 598.1 B | 429.1 B | 504.5 B | 825.2 B | 136.4 B | 240.6 B | -59.77 |
Net.Profit | 192.0 B | 225.5 B | 41.8 B | 37.2 B | 301.9 B | -180.9 B | -177.4 B | -178.67 |
EBITDA | 1.5 T | 687.0 B | 583.2 B | 638.4 B | 1.1 T | 565.4 B | 484.7 B | -29.45 |
Interest Expense | 59.1 B | 149.1 B | 357.1 B | 447.8 B | 448.5 B | 374.7 B | 410.4 B | |
RATIO | ||||||||
EPS | 34.28 | 40.26 | 7.47 | 6.64 | 53.92 | -32.31 | -31.67 | -178.66 |
PER | 79.93 x | 63.34 x | 388.22 x | 435.24 x | 44.51 x | -38.69 x | -22.10 x | |
BVPS | 436.58 | 501.28 | 1423.63 | 1245.1 | 1303.61 | 1312.68 | 1697.48 | |
PBV | 6.28 x | 5.09 x | 2.04 x | 2.32 x | 1.84 x | 0.95 x | 0.41 x | |
ROA | 0.0338 | 0.0261 | 0.0023 | 0.0021 | 0.016 | -0.0097 | -0.0086 | -132.95 |
ROE | 0.0792 | 0.081 | 0.0053 | 0.0054 | 0.0417 | -0.0248 | -0.0188 | -123.21 |
EV/EBITDA | 11.8 | 27.13 | 43.71 | 40.84 | 22.64 | 31.08 | 29.32 | |
Debt/Equity | 1.34 | 2.1 | 1.26 | 1.56 | 1.6 | 1.56 | 1.18 | |
Debt/TotalCap | 0.57 | 0.68 | 0.56 | 0.61 | 0.62 | 0.61 | 0.54 | |
Debt/EBITDA | 2.15 | 8.5 | 17.07 | 16.87 | 10.83 | 20.1 | 22.92 | |
EBITDA/IntExps | 25.57 | 4.61 | 1.63 | 1.43 | 2.39 | 1.51 | 1.18 | -74.40 |
Deviden | 14.98 | 16.33 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ![]() |
|||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
MARKET CAPITALIZATION | ||
Listed Share | 5.562.386.000 | |
Price | Rp. 725 | |
Capitalization | Rp. 4.033 B. | |
OWNERSHIP | ||
Listing Date : 04-Jul-01 | ||
Lokal 10,00 % | Asing 0,11 % | Lainnya 89,89 % |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 0 | |
Rating ROA | 1 | |
Rating EQUITY | 5 | |
Rating ROE | 0 | |
Rating DER | 4 | |
Rating TOTAL | 1 |
![]() | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | KAEF - Kimia Farma Tbk. | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (6) | : | MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Index (6) | : | MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Board | : | 6 Index MBX, IDXSMC-COM, ISSI, IDXMESBUMN, IDXHEALTH, COMPOSITE | ||
Fasilitas Marjin | : | Saham yang bisa diperdagangkan dengan fasilitas marjin | ||
Corporate Action | : | - | ||
TIME PERIOD : 01-12-2023 | |||
Close | 725 | Prev Close | 715 |
Change | 10 (1.4%) | Range | 705-725 |
Bid | 720 | Offer | 725 |
Bid Volume | 6100 | Offer Volume | 31400 |
Frequency | 260 | Value Rp.: 388.502.500 |
RETURN ON ASSET | |||||
---|---|---|---|---|---|
Benchmark to Others : | |||||
A Exceptional | |||||
B Excellent | |||||
C Very Good | |||||
D Good | |||||
E Fair | ![]() |
||||
F Poor | |||||
RATIO (%) | ≤ 0 |
0-0.4 | 0.4- 1.7 |
1.7- 3.6 |
> 3.6 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ![]() |
|||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |